Intermediate (Locally Aggressive) Blood Vessel Neoplasm

Intermediate (Locally Aggressive) Blood Vessel Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07656909	Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP	recruiting	Phase 2 / Phase 3	76	Yi JiOTHER	1	Jun 18, 2026	clinicaltrials
NCT04448873	Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma	completed	Phase 4	30	Children's Hospital of Fudan UniversityOTHER	1	Sep 26, 2023	clinicaltrials
NCT02110069	A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors	terminated	Phase 2	4	Boston Children's HospitalOTHER	1	Sep 21, 2023	clinicaltrials
NCT04077515	Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma

Data updated 22 days agoSource updated Jun 18, 2026source: clinicaltrials